Tirzepatide is a clinician-guided medication that supports appetite regulation and metabolic balance
The statements on this website have not been evaluated by the U.S
These priorities are intended to help clinicians provide practical, real-world nutrition and lifestyle counseling to increase benefits, reduce risks, and improve long-term outcomes for their patients using GLP-1s
doi:10.1177/20420188251406456
3.1.2 Exenatide As the first GLP-1R agonist approved for T2DM, EX is a new class of compound and a synthetic product of exendin-4, which is a compound naturally derived from the Gila monster and has multiple hypoglycemic mechanisms: inhibiting of glucagon release from cells, slowing of gastric emptying, decreasing appetite and increasing glucose-dependent insulin secretion (12, 46, 47)
Brain Metabolic Alterations in Rats Showing Depression-Like and Obesity Phenotypes